Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab

Chad J Hruska; Robert J Bertoli; Yorke D Young; Patrick H Burkhart; Paul B Googe

doi:10.1016/j.jdcr.2014.12.006

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab

JAAD Case Rep. 2015 Feb 5;1(2):56-9. doi: 10.1016/j.jdcr.2014.12.006. eCollection 2015 Mar.

Authors

Chad J Hruska¹, Robert J Bertoli¹, Yorke D Young¹, Patrick H Burkhart², Paul B Googe³

Affiliations

¹ University of Tennessee Graduate School of Medicine, Knoxville, Tennessee.
² Blount Dermatology, Maryville, Tennessee.
³ University of Tennessee Graduate School of Medicine, Knoxville, Tennessee; Knoxville Dermatopathology Laboratory, Knoxville, Tennessee; Vanderbilt University, Nashville, Tennessee.

No abstract available

Keywords: ALCL, anaplastic large cell lymphoma; CTCL, cutaneous T-cell lymphoma; Humira; LyP, lymphomatoid papulosis; PCALCL, primary cutaneous anaplastic large cell lymphoma; RA, rheumatoid arthritis; TNF, tumor necrosis factor; adalimumab; anaplastic large cell lymphoma; cutaneous T-cell lymphoma; lymphoma; therapeutics; tumor necrosis factor-alfa.

Publication types

Case Reports